|
Immunosporin: Klinische Wirksamkeit bei der frühen rheumatoiden Arthritis
rheuma-online » Medikamente » Ciclosporin (Immunosporin) » Ciclosporin (z.B. Immunosporin) im Detail » Wirksamkeit von Immunosporin bei der Therapie der rheumatoiden Arthritis » Wirksamkeit von Ciclosporin bei der frühen rheumatoiden Arthritis » Immunosporin: Klinische Wirksamkeit bei der frühen rheumatoiden Arthritis
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquine. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Röntgenprogression bei früher rheumatoider ArthritisProgression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Autor: Priv. Doz. Dr. med H. E. Langer |
|||||
|
||||||